Drug Shortage Report for ERYTHRO-BASE
Report ID | 134555 |
Drug Identification Number | 00682020 |
Brand name | ERYTHRO-BASE |
Common or Proper name | Erythro-Base |
Company Name | AA PHARMA INC |
Market Status | DORMANT |
Active Ingredient(s) | ERYTHROMYCIN |
Strength(s) | 250MG |
Dosage form(s) | TABLET |
Route of administration | ORAL ORAL |
Packaging size | 100BTL |
ATC code | J01FA |
ATC description | MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2021-02-22 |
Estimated end date | 2022-09-01 |
Actual end date | 2022-04-01 |
Shortage status | Resolved |
Updated date | 2022-04-02 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 1165 CREDITSTONE ROAD VAUGHAN, ONTARIO CANADA L4K 4N7 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.